BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31924157)

  • 1. Periodontal Pathogens and Neuropsychiatric Health.
    Wadhawan A; Reynolds MA; Makkar H; Scott AJ; Potocki E; Hoisington AJ; Brenner LA; Dagdag A; Lowry CA; Dwivedi Y; Postolache TT
    Curr Top Med Chem; 2020; 20(15):1353-1397. PubMed ID: 31924157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of Porphyromonas gingivalis and its virulence factors in periodontitis.
    Xu W; Zhou W; Wang H; Liang S
    Adv Protein Chem Struct Biol; 2020; 120():45-84. PubMed ID: 32085888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manipulation of Neutrophils by
    Sochalska M; Potempa J
    Front Cell Infect Microbiol; 2017; 7():197. PubMed ID: 28589098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of Important Virulence Factors of
    Jia L; Han N; Du J; Guo L; Luo Z; Liu Y
    Front Cell Infect Microbiol; 2019; 9():262. PubMed ID: 31380305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of RgpA in the pathogenicity of Porphyromonas gingivalis in the murine periodontitis model.
    Wilensky A; Polak D; Houri-Haddad Y; Shapira L
    J Clin Periodontol; 2013 Oct; 40(10):924-32. PubMed ID: 23909600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porphyromonas gulae Has Virulence and Immunological Characteristics Similar to Those of the Human Periodontal Pathogen Porphyromonas gingivalis.
    Lenzo JC; O'Brien-Simpson NM; Orth RK; Mitchell HL; Dashper SG; Reynolds EC
    Infect Immun; 2016 Sep; 84(9):2575-85. PubMed ID: 27354442
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Bartnicka D; Gonzalez-Gonzalez M; Sykut J; Koziel J; Ciaston I; Adamowicz K; Bras G; Zawrotniak M; Karkowska-Kuleta J; Satala D; Kozik A; Zyla E; Gawron K; Lazarz-Bartyzel K; Chomyszyn-Gajewska M; Rapala-Kozik M
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183255
    [No Abstract]   [Full Text] [Related]  

  • 8. Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen.
    Bostanci N; Belibasakis GN
    FEMS Microbiol Lett; 2012 Aug; 333(1):1-9. PubMed ID: 22530835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaking bad: manipulation of the host response by Porphyromonas gingivalis.
    Hajishengallis G; Lamont RJ
    Eur J Immunol; 2014 Feb; 44(2):328-38. PubMed ID: 24338806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porphyromonas gingivalis may play an important role in the pathogenesis of periodontitis-associated rheumatoid arthritis.
    Liao F; Li Z; Wang Y; Shi B; Gong Z; Cheng X
    Med Hypotheses; 2009 Jun; 72(6):732-5. PubMed ID: 19246161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Heart Failure Prevalence in Patients with a High Antibody Level Against Periodontal Pathogen.
    Aoyama N; Kure K; Minabe M; Izumi Y
    Int Heart J; 2019 Sep; 60(5):1142-1146. PubMed ID: 31447467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease.
    Kesavalu L; Sathishkumar S; Bakthavatchalu V; Matthews C; Dawson D; Steffen M; Ebersole JL
    Infect Immun; 2007 Apr; 75(4):1704-12. PubMed ID: 17210663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D reduces the inflammatory response by Porphyromonas gingivalis infection by modulating human β-defensin-3 in human gingival epithelium and periodontal ligament cells.
    De Filippis A; Fiorentino M; Guida L; Annunziata M; Nastri L; Rizzo A
    Int Immunopharmacol; 2017 Jun; 47():106-117. PubMed ID: 28384529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum C-reactive protein and immunoglobulin G antibodies to periodontal pathogens may be effect modifiers of periodontitis and hyperglycemia.
    Choi YH; McKeown RE; Mayer-Davis EJ; Liese AD; Song KB; Merchant AT
    J Periodontol; 2014 Sep; 85(9):1172-81. PubMed ID: 24410292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periodontitis induced by
    Blasco-Baque V; Garidou L; Pomié C; Escoula Q; Loubieres P; Le Gall-David S; Lemaitre M; Nicolas S; Klopp P; Waget A; Azalbert V; Colom A; Bonnaure-Mallet M; Kemoun P; Serino M; Burcelin R
    Gut; 2017 May; 66(5):872-885. PubMed ID: 26838600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct gene expression characteristics in epithelial cell-
    Zhang D; Hou J; Wu Y; Liu Y; Li R; Xu T; Liu J; Pan Y
    Int J Med Sci; 2019; 16(10):1320-1327. PubMed ID: 31692996
    [No Abstract]   [Full Text] [Related]  

  • 17. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response.
    Polak D; Wilensky A; Shapira L; Halabi A; Goldstein D; Weiss EI; Houri-Haddad Y
    J Clin Periodontol; 2009 May; 36(5):406-10. PubMed ID: 19419440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Converging findings from linkage between periodontal pathogen with atopic and allergic immune response.
    Nelwan SC; Nugraha RA; Endaryanto A; Meizarini A; Tedjosasongko U; Pradopo S; Utomo H
    Cytokine; 2019 Jan; 113():89-98. PubMed ID: 29937409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell response mediated by myeloid cell-derived IL-12 is responsible for Porphyromonas gingivalis-induced periodontitis in IL-10-deficient mice.
    Sasaki H; Suzuki N; Kent R; Kawashima N; Takeda J; Stashenko P
    J Immunol; 2008 May; 180(9):6193-8. PubMed ID: 18424741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of inflammatory responses of human gingival fibroblasts by gingipains from Porphyromonas gingivalis.
    Palm E; Khalaf H; Bengtsson T
    Mol Oral Microbiol; 2015 Feb; 30(1):74-85. PubMed ID: 25055828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.